Improve Medical Technology (Nanxiong) Co., Ltd., hereinafter referred to as "Nximprove Medical", whose parent company is Guangzhou Improve Medical Instruments Co., Ltd. who is a listed company under the ticker symbol "300030", founded in 2011. Nximprove Medical is located in Fine Chemical Industry Park of Nanxiong, covers an area of 50 acres and has the first investment of RMB25 million.
Our company is mainly producing medical chemicals, including two fields-medicine and chemistry. We are continuously developing and innovating chemical products to solve medical problems. Our company has been primarily engaged in researching, developing and selling core chemical intermediates and high-end pharmaceutical intermediates which required for clinical diagnosis reagents.
Our early products are separator gel and blood clotting accelerant, which are mainly supplied to our parent company. In the first period, we have built the production capacity of an annual output of 600 tons of separator gel and 10,000 liters of blood clotting accelerant.
Our company adheres to the philosophy of "Innovation Leading Development of Enterprises", focuses on research and development, and increases investment in hardware and software.
Our company is conducting standard R&D and operation according to specification requirements of high-tech enterprises. We planned to apply for the high-tech enterprise in 2013.
Our company will adhere to the core value of "Security, Integrity, Excellence, Pleasure", and take technological innovation as the core motivation of enterprise development, and scientific quality management as the reliable guarantee of product quality. We regard "care for human health" as our mission, in order to achieve the win-win with our clients, shareholders, staff members and the society.
China (Mainland)Business Type: Trading Company
